1. Mol Cell. 2020 May 7;78(3):522-538.e9. doi: 10.1016/j.molcel.2020.03.007. Epub
 2020 Mar 26.

4D Genome Rewiring during Oncogene-Induced and Replicative Senescence.

Sati S(1), Bonev B(2), Szabo Q(2), Jost D(3), Bensadoun P(4), Serra F(5), 
Loubiere V(2), Papadopoulos GL(2), Rivera-Mulia JC(6), Fritsch L(2), Bouret 
P(7), Castillo D(5), Gelpi JL(8), Orozco M(9), Vaillant C(10), Pellestor F(11), 
Bantignies F(2), Marti-Renom MA(12), Gilbert DM(13), Lemaitre JM(14), Cavalli 
G(15).

Author information:
(1)Institute of Human Genetics, UMR 9002, CNRS and University of Montpellier, 
Montpellier, France; Institute for Regenerative Medicine and Biotherapy, Univ 
Montpellier, INSERM UMR1183, F-34295 Montpellier, France.
(2)Institute of Human Genetics, UMR 9002, CNRS and University of Montpellier, 
Montpellier, France.
(3)Univ Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000 Grenoble, France.
(4)Institute for Regenerative Medicine and Biotherapy, Univ Montpellier, INSERM 
UMR1183, F-34295 Montpellier, France.
(5)CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science 
and Technology, Barcelona 08028, Spain.
(6)Department of Biochemistry, Molecular Biology and Biophysics, University of 
Minnesota Medical School, Minneapolis, MN 55455, USA.
(7)Unit of Chromosomal Genetics and Chromostem Research Platform, CHU, 
Montpellier, France.
(8)Barcelona Supercomputing Center, Barcelona, Spain; Department of Biochemistry 
and Molecular Biomedicine, University of Barcelona, Barcelona, Spain.
(9)Department of Biochemistry and Molecular Biomedicine, University of 
Barcelona, Barcelona, Spain; Institute for Research in Biomedicine, the 
Barcelona Institute of Science and Technology, Barcelona, Spain.
(10)Laboratoire de Physique (UMR CNRS 5672), ENS de Lyon, Lyon, France.
(11)Institute for Regenerative Medicine and Biotherapy, Univ Montpellier, INSERM 
UMR1183, F-34295 Montpellier, France; Unit of Chromosomal Genetics and 
Chromostem Research Platform, CHU, Montpellier, France.
(12)CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science 
and Technology, Barcelona 08028, Spain; Centre for Genomic Regulation, The 
Barcelona Institute for Science and Technology, Carrer del Doctor Aiguader 88, 
Barcelona 08003, Spain; Pompeu Fabra University, Doctor Aiguader 88, Barcelona 
08003, Spain; CREA, PgLluís Companys 23, 08010 Barcelona, Spain.
(13)Department of Biological Science and Center for Genomics and Personalized 
Medicine, Florida State University, Tallahassee, FL 32306, USA.
(14)Institute for Regenerative Medicine and Biotherapy, Univ Montpellier, INSERM 
UMR1183, F-34295 Montpellier, France; CHRU de Montpellier, Montpellier, France. 
Electronic address: jean-marc.lemaitre@inserm.fr.
(15)Institute of Human Genetics, UMR 9002, CNRS and University of Montpellier, 
Montpellier, France. Electronic address: giacomo.cavalli@igh.cnrs.fr.

Comment in
    Cancer Discov. 2020 May;10(5):639. doi: 10.1158/2159-8290.CD-RW2020-052.

To understand the role of the extensive senescence-associated 3D genome 
reorganization, we generated genome-wide chromatin interaction maps, epigenome, 
replication-timing, whole-genome bisulfite sequencing, and gene expression 
profiles from cells entering replicative senescence (RS) or upon 
oncogene-induced senescence (OIS). We identify senescence-associated 
heterochromatin domains (SAHDs). Differential intra- versus inter-SAHD 
interactions lead to the formation of senescence-associated heterochromatin foci 
(SAHFs) in OIS but not in RS. This OIS-specific configuration brings active 
genes located in genomic regions adjacent to SAHDs in close spatial proximity 
and favors their expression. We also identify DNMT1 as a factor that induces 
SAHFs by promoting HMGA2 expression. Upon DNMT1 depletion, OIS cells transition 
to a 3D genome conformation akin to that of cells in replicative senescence. 
These data show how multi-omics and imaging can identify critical features of RS 
and OIS and discover determinants of acute senescence and SAHF formation.

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

DOI: 10.1016/j.molcel.2020.03.007
PMCID: PMC7208559
PMID: 32220303 [Indexed for MEDLINE]

Conflict of interest statement: Declaration of Interests The authors declare no 
competing interests.